Recerca > Altres línies

Altres línies

Nombre de publicacions
590
Cercador de publicacions

  • Muniesa Royo M; March de Ribot A; Sánchez-de-la-Torre M; Huerva Escanilla V; Jurjo Campo C; Barbé Illa F

    Corneal Biomechanical Properties in Floppy Eyelid Syndrome

    Cornea 34 521-524. .

    [doi:10.1097/ICO.0000000000000396]

  • Eritja N; Santacana M; Maiques O; Gonzalez-Tallada X; Dolcet X; Matias-Guiu X

    Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: Endometrial cancer as a model

    Methods 77-78 31-40. .

    [doi:10.1016/j.ymeth.2014.11.001]

  • Porcel JM; Gasol A; Bielsa S; Civit C; Light RW; Salud A

    Clinical features and survival of lung cancer patients with pleural effusions

    RESPIROLOGY 20 654-659. .

    [doi:10.1111/resp.12496]

  • Garcia-Alfonso P; Chaves M; Muñoz A; Salud A; García-Gonzalez M; Grávalos C; Massuti B; González-Flores E; Queralt B; López-Ladrón A; Losa F; Gómez MJ; Oltra A; Aranda E

    Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

    Bmc Cancer 15 327-327. .

    [doi:10.1186/s12885-015-1293-y]

  • Perez-Calvo, Juan I.; Sanchez-Marteles, Marta; Morales-Rull, Jose L.

    beta blockers in patients with heart failure and atrial fibrillation

    Lancet 385 1617-1618. .

    [doi:10.1016/S0140-6736(15)60787-5]

  • Alonso-Alconada, L.; Santacana, M.; Garcia-Sanz, P.; Muinelo-Romay, L.; Colas, E.; Mirantes, C.; Monge, M.; Cueva, J.; Oliva, E.; Soslow, R.A.; Lopez, M.A.; Palacios, J.; Prat, J.; Valls, J.; Krakstad, C.; Salvesen, H.; Gil-Moreno, A.; Lopez-Lopez, R.; Dolcet, X.; Moreno-Bueno, G.; Reventos, J.; Matias-Guiu, X.; Abal, M.

    Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    INTERNATIONAL JOURNAL OF CANCER 136 1863-1873. .

    [doi:10.1002/ijc.29213]

  • Real J; Galindo G; Galván L; Lafarga MA; Rodrigo MD; Ortega M

    Use of Oral Bisphosphonates in Primary Prevention of Fractures in Postmenopausal Women: A Population-Based Cohort Study

    PLOS ONE 10 -. .

    [doi:10.1371/journal.pone.0118178]

  • Alés-Martínez, J.E.; Ruiz, A.; Chacón, J.I.; Lluch Hernández, A.; Ramos, M.; Córdoba, O.; Aguirre, E.; Barnadas, A.; Jara, C.; González, S.; Plazaola, A.; Florián, J.; Andrés, R.; Sánchez Rovira, P.; Frau, A.

    Preventive treatments for breast cancer: recent developments

    CLINICAL & TRANSLATIONAL ONCOLOGY 17 257-263. .

    [doi:10.1007/s12094-014-1250-2]

  • Sánchez-de-la-Torre M; Nadal N; Cortijo A; Masa JF; Duran-Cantolla J; Valls J; Serra S; Sánchez-de-la-Torre A; Gracia M; Ferrer F; Lorente I; Urgeles MC; Alonso T; Fuentes A; Armengol F; Lumbierres M; Vázquez-Polo FJ; Barbé F

    Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: a randomised controlled trial

    Thorax 70 346-352. .

    [doi:10.1136/thoraxjnl-2014-206287]

  • Martín M; Loibl S; von Minckwitz G; Morales S; Martinez N; Guerrero A; Anton A; Aktas B; Schoenegg W; Muñoz M; Garcia-Saenz JÁ; Gil M; Ramos M; Margeli M; Carrasco E; Liedtke C; Wachsmann G; Mehta K; De la Haba-Rodriguez JR

    Phase III Trial Evaluating the Addition of Bevacizumab to Endocrine Therapy As First-Line Treatment for Advanced Breast Cancer: The Letrozole/Fulvestrant and Avastin (LEA) Study

    Journal of Clinical Oncology 33 1045-1045. .

    [doi:10.1200/JCO.2014.57.2388]

  • Alonso, N.; Traveset, A.; Rubinat, E.; Ortega, E.; Alcubierre, N.; Sanahuja, J.; Hernández, M.; Betriu, A.; Jurjo, C.; Fernández, E.; Mauricio, D.

    Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy

    Cardiovascular Diabetology 14 -. .

    [doi:10.1186/s12933-015-0196-1]

  • González-López, T.J.; Pascual, C.; Álvarez-Román, M.T.; Fernández-Fuertes, F.; Sánchez-González, B.; Caparrós, I.; Jarque, I.; Mingot-Castellano, M.E.; Hernández-Rivas, J.A.; Martín-Salces, M.; Solán, L.; Beneit, P.; Jiménez, R.; Bernat, S.; Andrade, M.M.; Cortés, M.; Cortti, M.J.; Pérez-Crespo, S.; Gómez-Núñez, M.; Olivera, P.E.; Pérez-Rus, G.; Martínez-Robles, V.; Alonso, R.; Fernández-Rodríguez, A.; Arratibel, M.C.; Perera, M.; Fernández-Miñano, C.; Fuertes-Palacio, M.A.; Vázquez-Paganini, J.A.; Gutierrez-Jomarrón, I.; Valcarce, I.; de Cabo, E.; Sainz, A.; Fisac, R.; Aguilar, C.; Paz Martínez-Badas, M.; Peñarrubia, M.J.; Calbacho, M.; de Cos, C.; González-Silva, M.; Coria, E.; Alonso, A.; Casaus, A.; Luaña, A.; Galán, P.; Fernández-Canal, C.; Garcia-Frade, J.; González-Porras, J.R.

    Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

    AMERICAN JOURNAL OF HEMATOLOGY 90 40-43. .

    [doi:10.1002/ajh.23900]